Trial Profile
Phase II trial of gimatecan in patients with recurrent epithelial ovarian, fallopian or peritoneal cancer in China
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Aug 2013
Price :
$35
*
At a glance
- Drugs Gimatecan (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- Sponsors Lee's Pharmaceutical
- 07 Aug 2013 New trial record